HPQ:NYSEHP Inc. Analysis
Data as of 2026-05-22 - not real-time
$21.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
HP Inc. trades around $21.9, delivering a PE of 8.3, far below the computer‑hardware industry average of ~39. The company posted 6.9% revenue growth and a free‑cash‑flow conversion of roughly $2.8 B, supporting its 5.7% dividend yield. With a payout ratio of 44%, the dividend appears sustainable given strong operating cash flow. However, HP carries $10.9 B of debt against $3.2 B of cash and a negative book value per share, raising balance‑sheet concerns. The DCF model implies a fair value near $45, suggesting a substantial upside relative to the current price, while analyst consensus targets hover around $20, indicating mixed expectations. Overall, the fundamentals paint a value‑oriented case with attractive income.
Technically, the stock sits above its 20‑day (≈$20.9) and 50‑day (≈$19.9) moving averages but below the 200‑day level, yielding a neutral trend. RSI at 61 signals modest momentum, yet the MACD histogram is negative and the signal line is bearish, hinting at short‑term pressure. Support near $19.5 and resistance around $22.8 frame the near‑term range. Recent news of a fresh dividend declaration and corporate resolutions to spur growth have lifted the share price, while the market’s “Extreme Greed” sentiment adds bullish bias. Volatility remains high at 45% over 30 days, and beta near 1 suggests the stock moves with the broader market, warranting caution. In this context, investors may consider a hold stance in the short run, with a tilt toward buying on dips.
Technically, the stock sits above its 20‑day (≈$20.9) and 50‑day (≈$19.9) moving averages but below the 200‑day level, yielding a neutral trend. RSI at 61 signals modest momentum, yet the MACD histogram is negative and the signal line is bearish, hinting at short‑term pressure. Support near $19.5 and resistance around $22.8 frame the near‑term range. Recent news of a fresh dividend declaration and corporate resolutions to spur growth have lifted the share price, while the market’s “Extreme Greed” sentiment adds bullish bias. Volatility remains high at 45% over 30 days, and beta near 1 suggests the stock moves with the broader market, warranting caution. In this context, investors may consider a hold stance in the short run, with a tilt toward buying on dips.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Dividend yield remains attractive
- Price near resistance with bearish MACD
- Support level provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Low PE vs industry
- Strong free cash flow supports dividend
- Potential upside to DCF fair value
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Balance‑sheet leverage limits aggressive upside
- Stable cash flow and dividend income
- Sector demand for PCs and printing remains steady
Key Metrics & Analysis
Financial Health
Revenue Growth6.90%
Profit Margin4.46%
P/E Ratio8.3
ROA5.62%
P/B Ratio-26.2
Op. Cash Flow$3.7B
Free Cash Flow$2.8B
Industry P/E39.1
Technical Analysis
TrendNeutral
RSI61.5
Support$19.50
Resistance$22.78
MA 20$20.93
MA 50$19.85
MA 200$23.10
MACDBearish
VolumeStable
Fear & Greed Index91.5
Valuation
Fair Value$45.26
Target Price$19.62
Upside/Downside-10.42%
GradeUndervalued
TypeValue
Dividend Yield5.70%
Risk Assessment
Beta0.95
Volatility45.06%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.